Anti-Infectives Drug Development Summit - April 2021 - Digital Event

Conference themes
Infectious diseases are one of the largest threats to global public health. The focus on the threat has never been greater, with the COVID-19 pandemic demonstrating the critical need for a more proactive approach within governments, biopharma, and investment communities to overcome the pressing issues in anti-infective drug development to combat antimicrobial resistance.

Professional congress organizer (PCO)
Hanson Wade

Notes
Speakers: Ercem Atillasoy Chief Regulatory and Safety Officer AlloVir, Martin Everett Chief Scientific Officer AntaBio, Glenn Dale Chief Development Officer BioVersys and more.

https://go.evvnt.com/717995-2?pid=4832

Mr. Customer Service